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Page 516
Interventional Cardiology
Post-Procedural TIMI Score Predicts 1 Year Mortality in ACS Patients
Ndrepepa and colleagues assessed the impact of baseline and post-proceduralThrombolysis In Myocardial Infarction (TIMI) blood flow grade on 1-year
mortality in over 10,000 patients with acute coronary syndromes (ACS) undergoing
percutaneous coronary intervention. Post-procedural TIMI flow grade more strongly
predicted 1-year mortality than the initial TIMI flow grade. This study suggests that
restoring normal epicardial flow improvesmortality in ACS patients.See page512.
See figure.
Coronary Spasm
Re-Examining the Significance of CAS
There are 2 reports on coronary artery spasm (CAS) in this issue.Wakabayashi andcolleagues tested Japanese patients for CAS 10 to 20 days after acute myocardial
infarction treated by percutaneous coronary intervention. Spasm was provoked in
approximately 75% of cases and these patients were almost 2 timesmore likely to have
an event during follow-up. Ong and colleagues tested patients presenting with ACS in
whom electrocardiogram abnormalities and biomarker elevation were present, but not
obstructive coronary artery disease. Spasm was provoked in 50%, suggesting that
CAS may be the etiology of chest pain in these patients. These 2 studies suggest that
CAS may not only be the cause for chest pain in some patients, but may also identify
higher-risk patients. See pages 518, 523, and 528.
Page 537
Heart Failure
Early BNP Assessment May Speed Diagnosis and Treatment of HF
Maisel and colleagues hypothesized that measuring B-type natriuretic peptide(BNP) early after presentation to the emergency department would reduce the
time to diagnosis of decompensated heart failure (HF) and thereby to treatment with
diuretics. Using data collected from the ADHERE registry, patients with the longest
time to BNP measurement also had the longest time to treatment. The later the
treatment took place, the fewer patients were asymptomatic at the time of hospital
discharge. This study confirms the hypothesis that delays in measuring BNP are
associated with delays in the administration of diuretics.See page534. See figure.
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Heart Rhythm Disorders
Settings and Testing for Initial ICD Implantations
The need for routine defibrillation threshold testing (DFT) for all patients under-going implantable cardioverter-defibrillator (ICD) placement and the optimal
initial detection and treatment algorithms are addressed in 2 articles in this issue.
Wilkoff and colleagues show that standardized settings to distinguish supraventricular
and ventricular tachyarrhythmias and the use of anti-tachycardia pacing safely reduced
the frequency of shocks. Blatt and colleagues used data from the SCD-HeFT trial to
assess outcomes based on initial DFT testing. A total of 98% of patients had a DFT
20 J; there was no difference in survival or shock efficacy between patients who had
a DFT 10 J and those who had a DFT 10 J. These 2 studies suggest that DFT
testing is not mandatory and that careful initial programming can safely reduce the
frequency of shocks. See pages 541, 551, and 557. See figure.
Page 563
Hypertrophic Cardiomyopathy
CMR for the Diagnosis of Hypertrophic Cardiomopathy
Olivotto and colleagues performed cardiovascular magnetic resonance (CMR)imaging on almost 300 patients with hypertrophic cardiomyopathy (HCM).
While the average left ventricular (LV)mass index was higher inHCMpatients, it was
within 2 SDs of the control measurements (i.e., 95th percentile) in 21% of con-
firmedHCMpatients. This occurredmost often in patientswith focal wall thickening,
rather than global thickening. This study demonstrates that the LVmass indexmay be
normal in some patients with HCM and cannot be used to exclude this diagnosis.
See page 559. See figure.
